comparemela.com

Page 12 - Mobile Palm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HHS secretary outlines plans for reproductive health care after Dobbs decision

Following the Supreme Court's decision on Dobbs v. Jackson Women’s Health Organization, HHS Secretary Xavier Becerra announced the department’s plans for enabling access to reproductive health care at a press conference.

Gene therapy safe, improves vision in X-linked retinitis pigmentosa in phase 1/2 study

Botaretigene sparoparvovec, an investigational gene therapy, was safe and improved vision in subjects with X-linked retinitis pigmentosa with disease-causing variants in the RPGR gene, according to a press release from MeiraGTx.

CGM improves time in range, reduces HbA1c for older adults with type 1 diabetes

Older adults with type 1 diabetes initiating continuous glucose monitoring for the first time had a reduction in time spent in hypoglycemia, improved time in range and a lower HbA1c, according to findings from a randomized clinical trial. In the Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) study, adults aged 60 years and older with type 1 diabetes randomly assigned to CGM had

PPIs linked to risk for severe infection, decompensation in patients with cirrhosis

LONDON — Exposure to proton pump inhibitors correlated with an increased risk for severe infection and cirrhosis decompensation among a subset of patients with cirrhosis, according to research presented at the International Liver Congress. “The safety of PPIs in cirrhosis remains quite controversial,” Nadim Mahmud, MD, MS, MPH, MSCE, assistant professor of medicine and

Joseph discusses AHA statement on managing CV risk in type 2 diabetes care

PHILADELPHIA — In this Healio video exclusive, Joshua J. Joseph, MD, MPH, FAHA, discussed the recent American Heart Association scientific statement on health equity in managing CV risk in type 2 diabetes.As Healio previously reported, the scientific statement, published in Circulation, is based on an extensive review of clinical trial results through June 2020 and addresses the managing of

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.